Although we see a clear difference in the amount of foci in tumors with and without deletions in CDKN2A or RB1, this study is based on a small heterogenous group of chondrosarcomas and measurements are taken after 2 or 24 h. This evidence concerns the gene CDKN2A and chondrosarcoma.